Hangzhou Biotest Biotech Co.,Ltd.
SHH: 688767.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Shujiang Wu
- Employees
- 603
- Headquarters
- Hangzhou, China
- IPO year
- 2021
- Market cap
- CN¥6.2B
- Website
- https://www.biotests.com.cn
Loading 688767…
Loading profile data…Frequently asked questions about 688767
What does Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) do?
Hangzhou Biotest Biotech Co., LTD. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and equipment in China and Internationally. It offers medical test products for fertility health, oncology, cardiology, inflammation, biochemistry, and various infectious diseases, as well as COVI...
Where does 688767.SS trade?
Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) trades on the Shanghai Stock Exchange.
What sector is 688767.SS in?
Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Hangzhou Biotest Biotech Co.,Ltd.?
Shujiang Wu is the chief executive officer of Hangzhou Biotest Biotech Co.,Ltd. (688767.SS).
Where is Hangzhou Biotest Biotech Co.,Ltd. headquartered?
Hangzhou Biotest Biotech Co.,Ltd. is headquartered in China.
Does 688767.SS pay a dividend?
Yes — Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) paid a trailing twelve-month dividend of CNY 0.71 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688767.SS go public?
Hangzhou Biotest Biotech Co.,Ltd. (688767.SS) completed its initial public offering in 2021.